Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
14.53
+0.68 (4.91%)
At close: Jun 16, 2026
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $19.5 million as of June 16, 2026. Its market cap has increased by 156.55% in one year.
Market Cap
19.50M
Enterprise Value
-182.41M
1-Year Change
156.55%
Ranking
Category
Stock Price
$14.53
Market Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has decreased from $558.65M to $19.50M, a decrease of -96.51%. That is a compound annual growth rate of -46.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 19.34M | 43.74% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 21.28M |
| VYNE Therapeutics | 21.09M |
| Polyrizon | 20.59M |
| Cellectar Biosciences | 19.58M |
| Atossa Therapeutics | 19.12M |
| Lipocine | 18.96M |
| Tempest Therapeutics | 18.00M |
| Werewolf Therapeutics | 17.74M |